Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia

NCT06080555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency
Anaemia

Interventions

DRUG: Ferric Carboxymaltose Injection
DRUG: Ferric Carboxymaltose Injection [Ferinject]

Sponsor

Sichuan Huiyu Pharmaceutical Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]